COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY

LIVE

Serial Number

87646713

Owner

TEVA Pharmaceutical Industries Limited

Attorney

Laurence Rickles

First Use Date

Jan 28, 2014

Filing Date

Oct 16, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY Trademark

Serial Number: 87646713 • Registration: 5533589

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY is a trademark filed by TEVA Pharmaceutical Industries Limited on October 16, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

TEVA Pharmaceutical Industries Limited (147 trademarks)

Science Based Industries Campus
Tel Aviv 6944020 , IL

Entity Type: 99

Legal Representation

Attorney of Record

Laurence Rickles

292 trademarks filed View all →

Trademark Details

Filing Date

October 16, 2017

Registration Date

August 7, 2018

First Use Anywhere

January 28, 2014

First Use in Commerce

January 28, 2014

Published for Opposition

May 22, 2018

Goods & Services

Pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis containing glatiramer acetate

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Oct 10, 2024 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Oct 10, 2024 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 10, 2024 APRE

TEAS SECTION 8 & 15 RECEIVED

Apr 11, 2024 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 7, 2023 REM1

REGISTERED-PRINCIPAL REGISTER

Aug 7, 2018 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 22, 2018 NPUB

PUBLISHED FOR OPPOSITION

May 22, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 2, 2018 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 18, 2018 CNSA

EXAMINER'S AMENDMENT ENTERED

Apr 18, 2018 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 18, 2018 GNEN

EXAMINERS AMENDMENT E-MAILED

Apr 18, 2018 GNEA

EXAMINERS AMENDMENT -WRITTEN

Apr 18, 2018 CNEA

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Apr 9, 2018 ZZZX

WITHDRAWN FROM PUB - OG REVIEW QUERY

Mar 20, 2018 PBCR

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 6, 2018 PREV

ASSIGNED TO LIE

Mar 5, 2018 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 27, 2018 CNSA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 23, 2018 TCCA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 23, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 23, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 23, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 1, 2018 GNRN

NON-FINAL ACTION E-MAILED

Feb 1, 2018 GNRT

NON-FINAL ACTION WRITTEN

Feb 1, 2018 CNRT

ASSIGNED TO EXAMINER

Jan 25, 2018 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 26, 2017 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 25, 2017 NWOS

NEW APPLICATION ENTERED

Oct 19, 2017 NWAP

Related Trademarks

More from this Owner

HUMANIZING HEALTH CARE

CENMIRA

TEVA

TEVA API

More in Same Class